Eledon Pharmaceuticals, Inc. · NASDAQ:ELDN
Gros David-Alexandre C received 354,454 Eledon Pharmaceuticals, Inc. shares as an award (Form 4)
Traded Jul 31, 2026 · Filed Aug 4, 2026
On Jul 31, 2026, Gros David-Alexandre C (Director, Chief Executive Officer) received 354,454 Eledon Pharmaceuticals, Inc. shares as an award, leaving 168,663 shares. Filed Aug 4, 2026 (Form 4).
- Awarded
- 354,454 shares
- Holding after
- 168,663 shares
- Trading plan
- No
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 31, 2026 | Common Stock | Award | 354,454 | 363,454 | Direct | |
| Jul 31, 2026 | Common Stock | Shares withheld for tax | 194,791 | US$3.38 | 168,663 | Direct |
Source
Related
- Eledon Pharmaceuticals, Inc.
- Gros David-Alexandre C
- Eledon Pharmaceuticals, Inc. shareholders
- Form 4 · Perrin Steven · Aug 4, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026
- Schedule 13G/A · Bvf Partners L P · May 15, 2026
- Schedule 13G · BlackRock, Inc. · Apr 27, 2026
- Schedule 13G/A · The Vanguard Group · Mar 26, 2026